EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Investigating the role of a conserved hydrophobic pocket of gp41 in the anti‐ HIV activity of fusion inhibitors

Daniel Polo-Megías iD, Mario Cano-Muñoz, Laura Sánchez-Martínez iD, Sara Lestani iD, Christiane Moog, Thomas Decoville, María Carmen Salinas-García, José Antonio Gavira, Ana Cámara-Artigas, Francisco Conejero-Lara

Protein Science · 2026-06 · 35 (6)

DOI: 10.1002/pro.70593 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Protein Science, online erschienen am 04.05.2026. Verfasst von Daniel Polo-Megías und 9 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Química Física, Instituto de Biotecnología y Unidad de Excelencia de Química Aplicada a Biomedicina y Medioambiente (UEQ), Facultad d…. Hauptthemen laut MEDLINE: HIV Envelope Protein gp41, HIV Fusion Inhibitors, HIV-1. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Estatal de Investigación, Agence Nationale de Recherches sur le Sida et les Hépatites Virales, European HIV vaccine alliance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Membrane fusion between HIV and host cells requires interaction between the N‐terminal and C‐terminal repeat regions (NHR and CHR) of the gp41 envelope subunit. A deep hydrophobic pocket (HP) on the surface of NHR is considered crucial in this interaction. Targeting the viral gp41 CHR with stabilized trimeric NHR peptides or chimeric proteins effectively inhibits HIV infection. However, the contribution of each specific structural element, particularly the HP, in this mode of inhibition remains unclear. Here, we describe three chimeric proteins that structurally mimic the full NHR region interacting intramolecularly with CHR segments of varying lengths, either covering or exposing the HP. The intramolecular NHR–CHR interaction strongly stabilized all the chimeras. Binding analysis using a CHR‐derived peptide and the hydrophobic probe 8‐anilino‐1‐naphthalene sulfonate (ANS) combined with X‐ray crystallography assessed the degree of exposure of the HP in the chimeras. Despite differences in HP accessibility, none of the chimeras displayed relevant inhibitory activity against several HIV‐1 strains, suggesting that an exposed HP alone is insufficient to disrupt the NHR–CHR interaction in a viral context. The crystal structure of the ANS–chimera complex revealed the binding pose of ANS within the HP, while the overall CHR–NHR interaction closely resembled the canonical post‐fusion six‐helix‐bundle structure. To our knowledge, this is the first crystallographic structure of a small molecule ligand independently bound to the HP. These findings provide insight into the role of the HP in NHR‐based fusion inhibitors and guide the design of new, more focused and effective HIV inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV Envelope Protein gp41HIV Fusion InhibitorsHIV-1Hydrophobic and Hydrophilic InteractionsHumansCrystallography, X-RayModels, Molecular

Stichwörter der Autor:innen

X‐ray crystallographyantiviralscalorimetrycoiled‐coilsfusion inhibitorsprotein stabilitysmall‐molecule inhibitors

Substanzen

HIV Envelope Protein gp41HIV Fusion Inhibitors

Autor:innen und Institutionen

  • Departamento de Química Física, Instituto de Biotecnología y Unidad de Excelencia de Química Aplicada a Biomedicina y Medioambiente (UEQ), Facultad de Ciencias, Universidad de Granada, Granada, Spain.
  • Laboratoire d'ImmunoRhumatologie Moléculaire, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR_S 1109, Institut Thématique Interdisciplinaire (ITI) de Médecine de Précision de Strasbourg, Transplan…
  • Vaccine Research Institute (VRI), Créteil, France.
  • Laboratorio de Estudios Cristalográficos, IACT-CSIC, Granada, Spain.
  • Department of Chemistry and Physics, University of Almería, Agrifood Campus of International Excellence (ceiA3), Research Center for Mediterranean Intensive Agrosystems and Agri-Food Biotechnology (CIAIMBITAL), Almería,…

ORCID-Profile: Daniel Polo-Megías, Laura Sánchez-Martínez, Sara Lestani

Förderung

  • Agencia Estatal de Investigación
  • Agence Nationale de Recherches sur le Sida et les Hépatites Virales
  • European HIV vaccine alliance
  • European Research & Development Fund
  • Agence Nationale de Reserches- The Investissements d'Avenir Program

Zitieren

APA

Polo-Megías, D., Cano-Muñoz, M., Sánchez-Martínez, L., Lestani, S., Moog, C., Decoville, T., Salinas-García, M. C., Gavira, J. A., Cámara-Artigas, A., & Conejero-Lara, F. (2026). Investigating the role of a conserved hydrophobic pocket of gp41 in the anti‐ HIV activity of fusion inhibitors. Protein Science, 35(6). https://doi.org/10.1002/pro.70593

Vancouver

Polo-Megías D, Cano-Muñoz M, Sánchez-Martínez L, Lestani S, Moog C, Decoville T, et al. Investigating the role of a conserved hydrophobic pocket of gp41 in the anti‐ HIV activity of fusion inhibitors. Protein Science. 2026;35(6). doi:10.1002/pro.70593

BibTeX
@article{PoloMegas2026,
  author = {Polo-Megías, Daniel and Cano-Muñoz, Mario and Sánchez-Martínez, Laura and Lestani, Sara and Moog, Christiane and Decoville, Thomas and Salinas-García, María Carmen and Gavira, José Antonio and Cámara-Artigas, Ana and Conejero-Lara, Francisco},
  title = {Investigating the role of a conserved hydrophobic pocket of gp41 in the anti‐ HIV activity of fusion inhibitors},
  journal = {Protein Science},
  year = {2026},
  volume = {35},
  number = {6},
  doi = {10.1002/pro.70593}
}
Kostenlos starten →